Nasal Adverse Events Associated With Attention-Deficit Hyperactivity Disorder (ADHD) Medications: A Systematic Review, Meta-Analysis, and Implications for the Otolaryngologist. [PDF]
Kamal T, Shah S, Ahmed U, Elhassan H.
europepmc +1 more source
Raynaud's phenomenon during treatment with lisdexamfetamine: risk of cerebral vasospasm? [PDF]
Pitliuk R, Fucci TPPDCS.
europepmc +1 more source
A Matching-Adjusted Indirect Comparison (MAIC) of Centanafadine versus Methylphenidate Hydrochloride in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): Short-Term Safety and Efficacy Outcomes: Comparaison indirecte ajustée par appariement (MAIC) entre centanafadine et le chlorhydrate de méthylphénidate chez les adultes atteints d'un trouble déficitaire de l'attention avec ou sans hyperactivité (TDAH) : Résultats en matière d'innocuité et d'efficacité à court terme. [PDF]
Schein J +7 more
europepmc +1 more source
In silico investigation of ketamine and methylphenidate drug-drug conjugate for MDD and ADHD treatment using MD simulations and MMGBSA. [PDF]
Asrar B, Ali N, Ali I, Naveed M.
europepmc +1 more source
Use of psychostimulants in the management of treatment-resistant major depressive disorder. [PDF]
Pucci SL.
europepmc +1 more source
Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making.
Gosling CJ +34 more
europepmc +1 more source
Efecct of methylphenidate in young rats submitted to the model of epilepsy with pilocarpine
maria isabel LINHARES
openalex +1 more source

